Loading...
Medical Ikkou Group Co.,Ltd.
3353.T•JPX
Industrials
Conglomerates
¥3240.00
¥140.00(4.52%)
Medical Ikkou Group Co.,Ltd. (3353.T) Financial Performance & Income Statement Overview
Review Medical Ikkou Group Co.,Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
21.28%
↑ 21.28%
Operating Income Growth
8.52%
↑ 8.52%
Net Income Growth
8.98%
↑ 8.98%
Operating Cash Flow Growth
-71.98%
↓ 71.98%
Operating Margin
3.50%
↑ 3.50%
Gross Margin
11.72%
↑ 11.72%
Net Profit Margin
2.34%
↑ 2.34%
ROE
8.18%
↑ 8.18%
ROIC
7.50%
↑ 7.50%
Medical Ikkou Group Co.,Ltd. (3353.T) Income Statement & Financial Overview
Review Medical Ikkou Group Co.,Ltd.'s (3353.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $13.30B | $12.43B | $11.48B | $11.18B |
| Cost of Revenue | $11.74B | $11.03B | $10.13B | $9.83B |
| Gross Profit | $1.56B | $1.40B | $1.36B | $1.36B |
| Gross Profit Ratio | $0.12 | $0.11 | $0.12 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.08B | $1.02B | $957.00M | $927.58M |
| Operating Expenses | $1.08B | $1.02B | $956.12M | $927.58M |
| Total Costs & Expenses | $12.81B | $12.05B | $11.08B | $10.75B |
| Interest Income | $4.09M | $0.00 | $1.30M | $979000.00 |
| Interest Expense | $19.29M | $0.00 | $13.35M | $13.62M |
| Depreciation & Amortization | $213.46M | $198.20M | $180.86M | $170.89M |
| EBITDA | $569.03M | $570.75M | $659.37M | $855.95M |
| EBITDA Ratio | $0.04 | $0.05 | $0.06 | $0.08 |
| Operating Income | $488.81M | $375.00M | $399.12M | $429.20M |
| Operating Income Ratio | $0.04 | $0.03 | $0.03 | $0.04 |
| Other Income/Expenses (Net) | -$156.52M | $58.00M | $66.03M | $242.25M |
| Income Before Tax | $332.29M | $433.00M | $465.15M | $671.45M |
| Income Before Tax Ratio | $0.02 | $0.03 | $0.04 | $0.06 |
| Income Tax Expense | $214.78M | $131.00M | $172.81M | $235.87M |
| Net Income | $133.86M | $290.00M | $280.18M | $429.33M |
| Net Income Ratio | $0.01 | $0.02 | $0.02 | $0.04 |
| EPS | $35.56 | $77.09 | $74.52 | $114.24 |
| Diluted EPS | $35.56 | $77.09 | $74.52 | $114.24 |
| Weighted Avg Shares Outstanding | $3.76M | $3.76M | $3.76M | $3.76M |
| Weighted Avg Shares Outstanding (Diluted) | $3.76M | $3.76M | $3.76M | $3.76M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan